Human papillomaviruses and non-melanoma skin cancer: Basic virology and clinical manifestations

Disease Markers

Volumn 23, Issue 4, 2007, Pages 247-259

  Nindl, Ingo ^a   Gottschling, Marc ^a   Stockfleth, Eggert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN E6;

CANCER PATIENT; CATTLE; CELL CULTURE; CLINICAL FEATURE; COTTONTAIL RABBIT PAPILLOMAVIRUS; DNA DAMAGE; DNA REPAIR; EPIDERMODYSPLASIA VERRUCIFORMIS; HORSE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNE SYSTEM; IN VITRO STUDY; KERATINOCYTE; MODEL; MOLECULAR MECHANICS; MUTATION; NON MELANOMA SKIN CANCER; NONHUMAN; PAPILLOMA VIRUS; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; REVIEW; RISK; SKIN CANCER; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION; VIROLOGY; VIRUS DETECTION; VIRUS TRANSFORMATION; VIRUS TYPING; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 34347361743     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/942650     Document Type: Review

References (155)

1. R. Marks, G. Rennie and T. Selwood, Malignant transformation of solar keratoses to squamous cell carcinoma, Lancet 1 (1988), 795-797.
2. T. Johnson, D. Rowe, B. Nelson and N. Swanson, Squamous cell carcinoma of the skin (excluding lip and oral mucosa), J Am Acad Dermatol 26 (1992), 467-484.
3. C. Cockerell, Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"), J Am Acad Dermatol 42 (2000), 11-17.
4. S. Euvrard, J. Kanitakis and A. Claudy, Skin cancers after organ transplantation, N Engl J Med 348 (2003), 1681-1691.
5. W. Fu and C. Cockerell, The actinic (solar) keratosis: a 21st-century perspective, Arch Dermatol 139 (2003), 66-70.
6. S. Miller, Biology of basal cell carcinoma (Part I), J Am Acad Dermatol 24 (1991), 1-13.
7. G. Bowden, Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling, Nat Rev Cancer 4 (2004), 23-35.
8. D. Slaughter, H. Southwick and W. Smejkal, Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin, Cancer 6 (1953), 963-968.
9. D. Miller and M. Weinstock, Nonmelanoma skin cancer in the United States: incidence, J Am Acad Dermatol 30 (1994), 774-778.
10. H. Gloster and D. Brodland, The epidemiology of skin cancer, Dermatol Surg 22 (1996), 217-226.
11. R. DePinho, The age of cancer, Nature 408 (2000), 248-254.
12. T. Diepgen and V. Mahler, The epidemiology of skin cancer, Br J Dermatol 146 (Suppl 61) (2002), 1-6.
13. B. Armstrong and A. Kricker, The epidemiology of UV induced skin cancer, J Photochem Photobiol B63 (2001), 8-18.
14. M. Staples, M. Elwood, R. Burton, J. Williams, R. Marks and G. Giles, Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985, Med J Aust 184 (2006), 6-10.
15. S. Salasche, Epidemiology of actinic keratoses and squamous cell carcinoma, J Am Acad Dermatol 42 (2000), 4-7.
16. E. Stockfleth, C. Ulrich, T. Meyer, R. Arndt and E. Christophers, Skin diseases following organ transplantation-risk factors and new therapeutic approaches, Transplant Proc 33 (2001), 1848-1853.
17. P. Boukamp, Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 26 (2005), 1657-1667.
18. P. Erb, J. Ji, M. Wernli, E. Kump, A. Glaser and S. Büchner, Role of apoptosis in basal cell and squamous cell carcinoma formation, Immunol Lett 100 (2005), 68-72.
19. M. Kripke, Ultraviolet radiation and immunology: something new under the sun-presidential address, Cancer Res 54 (1994), 6102-6105.
20. M. Kripke and M. Fisher, Immunologic parameters of ultraviolet carcinogenesis, J Natl Cancer Inst 57 (1976), 211-215.
21. D. Brash, A. Ziegler, A. Jonason, J. Simon, S. Kunala and D. Leffell, Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion, J Investig Dermatol Symp Proc 1 (1996), 136-142.
22. D. Jih, S. Lyle, R. Elenitsas, D. Elder and G. Cotsarelis, Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells, J Cutan Pathol 26 (1999), 113-118.
23. R. Gorlin, Nevoid basal-cell carcinoma syndrome, Medicine (Baltimore) 66 (1987), 98-113.
24. S. Shanley, J. Ratcliffe, A. Hockey, E. Haan, C. Oley, D. Ravine, N. Martin, C. Wicking and G. Chenevix-Trench, Nevoid basal cell carcinoma syndrome: review of 118 affected individuals, Am J Med Genet 50 (1994), 282-290.
25. V. Kimonis, A. Goldstein, B. Pastakia, M. Yang, R. Kase, J. DiGiovanna, A. Bale and S. Bale, Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome, Am J Med Genet 69 (1997), 299-308.
26. R. Johnson, A. Rothman, J. Xie, L. Goodrich, J. Bare, J. Bonifas, A. Quinn, R. Myers, D. Cox, E. Epstein Jr. and M. Scott, Human homolog of patched, a candidate gene for the basal cell nevus syndrome, Science 272 (1996), 1668-1671.
27. H. Hahn, C. Wicking, P. Zaphiropoulous, M. Gailani, S. Shanley, A. Chidambaram, I. Vorechovsky, E. Holmberg, A. Unden, S. Gillies, K. Negus, I. Smyth, C. Pressman, D. Leffell, B. Gerrard, A. Goldstein, M. Dean, R. Toftgard, G. Chenevix-Trench, B. Wainwright and A. Bale, Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome, Cell 85 (1996), 841-851.
28. A. Chidambaram, A. Goldstein, M. Gailani, B. Gerrard, S. Bale, J. DiGiovanna, A. Bale and M. Dean, Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients, Cancer Res 56 (1996), 4599-4601.
29. M. Alam and D. Ratner, Cutaneous squamous-cell carcinoma, N Engl J Med 344 (2001), 975-983.
30. A. Quinn, S. Sikkink and J. Rees, Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers, Genes Chromosomes, Cancer 11 (1994), 222-225.
31. I. Rehman, M. Takata, Y. Wu and J. Rees, Genetic change in actinic keratoses, Oncogene 12 (1996), 2483-2490.
32. I. Nindl, C. Dang, T. Forschner, R. Kuban, T. Meyer, W. Sterry and E. Stockfleth, Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling, Mol Cancer 5 (2006), 30.
33. J. Newton, R. Camplejohn and D. McGibbon, A flow cytometric study of the significance of DNA aneuploidy in cutaneous lesions, Br J Dermatol 117 (1987), 169-174.
34. A. Herzberg, B. Kerns, F. Honkanen, J. Pence, J. Iglehart and R. Kinney, DNA ploidy and proliferation index of soft tissue sarcomas determined by image cytometry of fresh frozen tissue, Am J Clin Pathol 97 (1992), S29-S37.
35. N. Dumaz, A. Stary, T. Soussi, L. Daya-Grosjean and A. Sarasin, Can we predict solar ultraviolet radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene? Mutat Res 307 (1994), 375-386.
36. A. Ziegler, A. Jonason, D. Leffell, J. Simon, H. Sharma, J. Kimmelman, L. Remington, T. Jacks and D. Brash, Sunburn and p53 in the onset of skin cancer, Nature 372 (1994), 773-776.
37. N. Soufir, J. Moles, C. Vilmer, C. Moch, O. Verola, J. Rivet, A. Tesniere, L. Dubertret and N. Basset-Seguin, P16 UV mutations in human skin epithelial tumors, Oncogene 18 (1999), 5477-5481.
38. V. Brown, C. Harwood, T. Crook, J. Cronin, D. Kelsell and C. Proby, p16INK4a and p14ARF Tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma, J Invest Dermatol 122 (2004), 1284-1292.
39. H. Kreimer-Erlacher, H. Seidl, B. Bäck, L. Cerroni, H. Kerl and P. Wolf, High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients, J Invest Dermatol 120 (2003), 676-682.
40. Z. Saridaki, T. Liloglou, A. Zafiropoulos, E. Koumantaki, O. Zoras and D. Spandidos, Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin, Br J Dermatol 148 (2003), 638-648.
41. H. Ananthaswamy and W. Pierceall, Molecular alterations in human skin tumors, Prog Clin Biol Res 376 (1992), 61-84.
42. S. Popp, S. Waltering, C. Herbst, I. Moll and P. Boukamp, UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas, Int J Cancer 99 (2002), 352-360.
43. A. Jonason, S. Kunala, G. Price, R. Restifo, H. Spinelli, J. Persing, D. Leffell, R. Tarone and D. Brash, Frequent clones of p53-mutated keratinocytes in normal human skin, Proc Natl Acad Sci USA 93 (1996), 14025-14029.
44. F. Moloney, H. Comber, P. O'Lorcain, P. O'Kelly, P. Conlon and G. Murphy, A population-based study of skin cancer incidence and prevalence in renal transplant recipients, Br J Dermatol 154 (2006), 498-504.
45. B. Akgül, J. Cooke and A. Storey, HPV-associated skin disease, J. Pathol 208 (2006), 165-175.
46. J. Doorbar, The papillomavirus life cycle, J Clin Virol 32 (2005), 7-15.
47. E.-M. de Villiers, C. Fauquet, T. Broker, H.-U. Bernard and H. zur Hausen, Classification of papillomaviruses, Virology 324 (2004), 17-27.
48. International Agency for Research on Cancer, IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, IARC Lyon France 64 (1995).
49. N. Muñoz, F. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. Shah, P. Snijders and C. Meijer, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med 348 (2003), 518-527.
50. A. Narechania, Z. Chen, R. DeSalle and R. Burk, Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses, J Virol 79 (2005), 15503-15510.
51. H. zur Hausen, Papillomaviruses and cancer: From basic studies to clinical application, Nat Rev Cancer 2 (2002), 342-350.
52. M. Gottschling, A. Köhler, E. Stockfleth and I. Nindl, Phylogenetic analysis of beta-papillomaviruses as inferred from nucleotide and amino acid sequence data, Mol Phylogenet Evol 42 (2007), 213-222.
53. I. Bravo and A. Alonso, Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth, J Virol 78 (2004), 13613-13626.
54. S. Garcia-Vallve, A. Alonso and I. Bravo, Papillomaviruses: different genes have different histories, Trends Microbiol 13 (2005), 514-521.
55. F. Lewandowsky and W. Lutz, Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis), Arch Dermatol Syphilol 141 (1922), 193-203.
56. S. Jablonska, J. Dabrowski and K. Jakubowicz, Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis, Cancer Res 32 (1972), 583-589.
57. G. Orth, S. Jablonska, M. Favre, O. Croissant, M. Jarzabek-Chorzelska and G. Rzesa, Characterization of two types of human papillomaviruses in lesions of Epidermodysplasia verruciformis, Proc Natl Acad Sci USA 75 (1978), 1537-1541.
58. S. Majewski and S. Jablonska, Human papillomavirus-associated tumors of the skin and mucosa, J Am Acad Dermatol 36 (1997), 659-685.
59. M. Favre, N. Ramoz and G. Orth, Human papillomaviruses: General features, Clin Dermatol 15 (1997), 181-198.
60. N. Wentzensen, R. Ridder, R. Kläs, S. Vinokurova, U. Schäfer and M. Doeberitz, Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions, Oncogene 21 (2002), 419-426.
61. H. Pfister, Chapter 8: Human papillomavirus and skin cancer, J Natl Cancer Inst Monogr (2003), 52-56.
62. M. Yutsudo and A. Hakura, Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with Epidermodysplasia verruciformis, Int J Cancer 39 (1987), 586-589.
63. K. Haller, F. Stubenrauch and H. Pfister, Differentiation-dependent transcription of the Epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions, Virology 214 (1995), 245-255.
64. R. Ostrow, M. Bender, M. Niimura, T. Seki, M. Kawashima, F. Pass and A. Faras, Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with Epidermodysplasia verruciformis, Proc Natl Acad Sci USA 79 (1982), 1634-1638.
65. H. Pfister and J. Ter Schegget, Role of HPV in cutaneous premalignant and malignant tumors, Clin Dermatol 15 (1997), 335-347.
66. S. Majewski and S. Jablonska, Do Epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 138 (2002), 649-654.
67. N. Ramoz, L. Rueda, B. Bouadjar, L. Montoya, G. Orth and M. Favre, Mutations in two adjacent novel genes are associated with Epidermodysplasia verruciformis, Nat Genet 32 (2002), 579-581.
68. N. Ramoz, L. Rueda, B. Bouadjar, M. Favre and G. Orth, A susceptibility locus for Epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus, J Invest Dermatol 112 (1999), 259-263.
69. N. Ramoz, A. Taieb, L. Rueda, L. Montoya, B. Bouadjar, M. Favre and G. Orth, Evidence for a nonallelic heterogeneity of Epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25, J Invest Dermatol 114 (2000), 1148-1153.
70. G. Keresztes, H. Mutai and S. Heller, TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins, BMC Genomics 4 (2003), 24.
71. K. Kurima, Y. Yang, K. Sorber and A. Griffith, Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and Epidermodysplasia verruciformis, Genomics 82 (2003), 300-308.
72. A. Antonsson, S. Karanfilovska, P. Lindqvist and B. Hansson, General acquisition of human papillomavirus infections of skin occurs in early infancy, J Clin Microbiol 41 (2003), 2509-2514.
73. I. Boxman, R. Berkhout, L. Mulder, M. Wolkers, J. Bouwes Bavinck, B. Vermeer and J. Ter Schegget, Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers, J Invest Dermatol 108 (1997), 712-715.
74. I. Boxman, L. Mulder, A. Russell, J. Bouwes Bavinck, A. Green and J. Ter Schegget, Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals, Br J Dermatol 141 (1999), 246-249.
75. I. Boxman, A. Russell, L. Mulder, J. Bouwes Bavinck, J. Ter Schegget, A. Green and Collaborators of the Nambour Prevention Study, Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and Epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs, Int J Cancer 86 (2000), 118-121.
76. A. Köhler, T. Forschner, T. Meyer, C. Ulrich, M. Gottschling, E. Stockfleth and I. Nindl, Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas, Br. J. Dermatol (in press).
77. L. Tieben, J. Ter Schegget, R. Minnaar, J. Bouwes Bavinck, R. Berkhout, B. Vermeer, M. Jebbink and H. Smits, Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers, J Virol Methods 42 (1993), 265-279.
78. V. Shamanin, H. Delius and E.M. de Villiers, Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies, J Gen Virol 75 (1994), 1149-1156.
79. R. Berkhout, L. Tieben, H. Smits, J. Bouwes Bavinck, B.Vermeer and J. Ter Schegget, Nested PCR approach for detection and typing of Epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients, J Clin Microbiol 33 (1995), 690-695.
80. C. Harwood, P. Spink, T. Surentheran, I. Leigh, E.-M. de Villiers, J. McGregor, C. Proby and J. Breuer, Degenerate and nested PCR: A highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts, J Clin Microbiol 37 (1999), 3545-3555.
81. O. Forslund, A. Antonsson, P. Nordin, B. Stenquist and B. Hansson, A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin, J Gen Virol 80 (1999), 2437-2443.
82. T. Meyer, R. Arndt, E. Christophers and E. Stockfleth, Frequency and spectrum of HPV types detected in cutaneous squamous-cell carcinomas depend on the HPV detection system: A comparison of four PCR assays, Dermatology 201 (2000), 204-211.
83. D. O'Connor, E. Kay, M. Leader, G. Murphy, G. Atkins, and M. Mabruk, Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: Correlation with human papillomaviruses? Diagn Mol Pathol 10 (2001), 190-199.
84. A. Brink, B. Lloveras, I. Nindl, D. Heideman, D. Kramer, R. Pol, M. Fuente, C. Meijer and P. Snijders, Development of a general-primer-PCR-reverse- line-blotting system for detection of beta and gamma cutaneous human papillomaviruses, J Clin Microbiol 43 (2005), 5581-5587.
85. M. de Koning, W. Quint, L. Struijk, B. Kleter, P. Wanningen, L. van Doorn, S. Weissenborn, M. Feltkamp and J. Ter Schegget, Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA, J Clin Microbiol 44 (2006), 1792-1800.
86. G. Astori, D. Lavergne, C. Benton, B. Hockmayr, K. Egawa, C. Garbe and E. de Villiers, Human papillomaviruses are commonly found in normal skin of immunocompetent hosts, J Invest Dermatol 110 (1998), 752-755.
87. C. Harwood, T. Surentheran, J. McGregor, P. Spink, I. Leigh, J. Breuer and C. Proby, Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals, J Med Virol 61 (2000), 289-297.
88. T. Meyer, R. Arndt, E. Christophers, I. Nindl and E. Stockfleth, Importance of human papillomaviruses for the development of skin cancer, Cancer Detect Prev 25 (2001), 533-547.
89. O. Forslund, H. Ly, C. Reid and G. Higgins, A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis, Br J Dermatol 149 (2003), 64-73.
90. H. Pfister, P. Fuchs, S. Majewski, S. Jablonska, I. Pniewska and M. Malejczyk, High prevalence of Epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population, Arch Dermatol Res 295 (2003), 273-279.
91. U. Wieland, A. Ritzkowsky, M. Stoltidis, S. Weissenborn, S. Stark, M. Ploner, S. Majewski, S. Jablonska, H. Pfister and P. Fuchs, Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 115 (2000), 124-128.
92. D. O'Connor, E. Kay, M. Leader, G. Atkins, G. Murphy and M. Mabruk, p53 codon 72 polymorphism and human papillomavirus associated skin cancer, J Clin Pathol 54 (2001), 539-542.
93. O. Forslund, A. Antonsson, G. Higgins, H. Ly, H. Delius, A. Hunziker and E.-M. de Villiers, Nucleotide sequence and phylogenetic classification of candidate human papilloma virus type 92, Virology 312 (2003), 255-260.
94. I. Nindl, A. Köhler, T. Meyer, T. Forschner, C. Meijer, P. Snijders, W. Sterry and E. Stockfleth, Detection of human papillomavirus DNA in primary squamous cell carcinoma and metastases, Br J Dermatol 154 (2006), 797-799.
95. S. Weissenborn, I. Nindl, K. Purdie, C. Harwood, C. Proby, J. Breuer, S. Majewski, H. Pfister and U. Wieland, Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers, J Invest Dermatol 125 (2005), 93-97.
96. L. Struijk, J. Bouwes Bavinck, P. Wanningen, E. van der Meijden, R. Westendorp, J. Ter Schegget and M. Feltkamp, Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma, J Invest Dermatol 121 (2003), 1531-1535.
97. J. Bouwes Bavinck, S. Stark, A. Petridis, M. Marugg, J. Ter Schegget, R. Westendorp, P. Fuchs, B. Vermeer and H. Pfister, The presence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses, Br J Dermatol 142 (2000), 103-109.
98. C. Masini, P. Fuchs, F. Gabrielli, S. Stark, F. Sera, M. Ploner, C. Melchi, G. Primavera, G. Pirchio, O. Picconi, P. Petasecca, M. Cattaruzza, H. Pfister and D. Abeni, Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals, Arch Dermatol 139 (2003), 890-894.
99. S. Stark, A. Petridis, S. Ghim, A. Jenson, J. Bouwes Bavinck, G. Gross, E. Stockfleth, P. Fuchs and H. Pfister, Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer, J Invest Dermatol 111 (1998), 696-701.
100. M. Feltkamp, R. Broer, F. di Summa, L. Struijk, Meijden van der, B. Verlaan, R. Westendorp, J. Ter Schegget, W. Spaan and J. Bouwes Bavinck, Seroreactivity to Epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer, Cancer Res 63 (2003), 2695-2700.
101. M. Karagas, H. Nelson, P. Sehr, T. Waterboer, T. Stukel, A. Andrew, A. Green, J. Bouwes Bavinck, A. Perry, S. Spencer, J. Rees, L. Mott and M. Pawlita, Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin, J Natl Cancer Inst 98 (2006), 389-395.
102. J. Boyle, R. Mackie, J. Briggs, B. Junor and T. Aitchison, Cancer, warts, and sunshine in renal transplant patients. A case-control study, Lancet 1 (1984), 702-705.
103. J. Bouwes Bavinck, B. Vermeer, F. Van der Woude, J. Vandenbroucke, G. Schreuder, J. Thorogood, G. Persijn and F. Claas, Relation between skin cancer and HLA antigens in renal-transplant recipients, N Engl J Med 325 (1991), 843-848.
104. S. Birkeland, H. Storm, L. Lamm, L. Barlow, I. Blohme, B. Forsberg, B. Eklund, O. Fjeldborg, M. Friedberg and L. Frodin, Cancer risk after renal transplantation in the Nordic countries, 1964-1986, Int J Cancer 60 (1995), 183-189.
105. M. Hartevelt, J. Bouwes Bavinck, A. Kootte, B. Vermeer and J. Vandenbroucke, Incidence of skin cancer after renal transplantation in The Netherlands, Transplantation 49 (1990), 506-509.
106. J. Bouwes Bavinck, D. Hardie, A. Green, S. Cutmore, A. MacNaught, B. O'Sullivan, V. Siskind, F. Van der Woude and I. Hardie, The risk of skin cancer in renal transplant recipients in Queensland, Australia.Afollow-up study, Transplantation 61 (1996), 715-721.
107. K. Blessing, K. McLaren, E. Benton, B. Barr, M. Bunney, I. Smith and G. Beveridge, Histopathology of skin lesions in renal allograft recipients-an assessment of viral features and dysplasia, Histopathology 14 (1989), 129-139.
108. S. Euvrard, Y. Chardonnet, C. Pouteil Noble, J. Kanitakis, M. Chignol, J. Thivolet and J. Touraine, Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients, Cancer 72 (1993), 2198-2206.
109. V. Shamanin, M. Glover, C. Rausch, C. Proby, I. Leigh, H. zur Hausen and E.-M. de Villiers, Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients, Cancer Res 54 (1994), 4610-4613.
110. L. de Jong-Tieben, R. Berkhout, H. Smits, J. Bouwes Bavinck, B. Vermeer, F. Van der Woude and J. Ter Schegget, High frequency of detection of Epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients, J Invest Dermatol 105 (1995), 367-371.
111. E.-M. de Villiers, D. Lavergne, K. McLaren and E. Benton, Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients, Int J Cancer 73 (1997), 356-361.
112. R. Berkhout, J. Bouwes Bavinck and J. Ter Schegget, Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients, J Clin Microbiol 38 (2000), 2087-2096.
113. L. de Jong-Tieben, R. Berkhout, J. Ter Schegget, B. Vermeer, J. de Fijter, J. Bruijn, R. Westendorp and J. Bouwes Bavinck, The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: A clinical study to assess risk factors for keratotic skin lesions and skin cancer, Transplantation 69 (2000), 44-49.
114. K. Purdie, T. Surentheran, J. Sterling, L. Bell, J. McGregor, C. Proby, C. Harwood and J. Breuer, Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals, J Invest Dermatol 125 (2005), 98-107.
115. C. Dang, A. Köhler, T. Forschner, P. Sehr, K. Michael, M. Pawlita, E. Stockfleth and I. Nindl, E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients, Br J Dermatol 155 (2006), 129-136.
116. T. Iftner, S. Bierfelder, Z. Csapo and H. Pfister, Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication, J Virol 62 (1988), 3655-3661.
117. T. Kiyono, K. Nagashima and M. Ishibashi, The primary structure of major viral RNA in a rat cell line transfected with type 47 human papillomavirus DNA and the transforming activity of its cDNA and E6 gene, Virology 173 (1989), 551-565.
118. T. Kiyono, A. Hiraiwa and M. Ishibashi, Differences in transforming activity and coded amino acid sequence among E6 genes of several papillomaviruses associated with Epidermodysplasia verruciformis, Virology 186 (1992), 628-639.
119. A. Hiraiwa, T. Kiyono, K. Segawa, K. Utsumi, M. Ohashi and M. Ishibashi, Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells, Virology 192 (1993), 102-111.
120. T. Yamashita, K. Segawa, Y. Fujinaga, T. Nishikawa and K. Fujinaga, Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8, Oncogene 8 (1993), 2433-2441.
121. A. Schmitt, J. Harry, B. Rapp, F. Wettstein and T. Iftner, Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1, J Virol 68 (1994), 7051-7059.
122. S. Caldeira, I. Zehbe, R. Accardi, I. Malanchi, W. Dong, M. Giarre, E.-M. de Villiers, R. Filotico, P. Boukamp and M. Tommasino, The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties, J Virol 77 (2003), 2195-2206.
123. K. Purdie, J. Pennington, C. Proby, S. Khalaf, E.-M. de Villiers, I. Leigh and A. Storey, The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence, EMBO J 18 (1999), 5359-5369.
124. E. de Villiers, A. Ruhland and P. Sekaric, Human papillomaviruses in non-melanoma skin cancer, Semin Cancer Biol 9 (1999), 413-422.
125. A. Ruhland and E.-M. de Villiers, Opposite regulation of the HPV 20-URR and HPV 27-URR promoters by ultraviolet irradiation and cytokines, Int J Cancer 91 (2001), 828-834.
126. S. Jackson and A. Storey, E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage, Oncogene 19 (2000), 592-598.
127. S. Jackson, C. Harwood, M. Thomas, L. Banks and A. Storey, Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins, Genes Dev 14 (2000), 3065-3073.
128. T. Iftner, M. Elbel, B. Schopp, T. Hiller, J. Loizou, K. Caldecott and F. Stubenrauch, Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1, EMBO J 21 (2002), 4741-4748.
129. S. Giampieri and A. Storey, Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18, Br J Cancer 90 (2004), 2203-2209.
130. S. Giampieri, R. Garcia-Escudero, J. Green and A. Storey, Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation, Oncogene 23 (2004), 5864-5870.
131. L. Chow and T. Broker, In vitro experimental systems for HPV: Epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences, Clin Dermatol 15 (1997), 217-227.
132. I. Boxman, L. Mulder, F. Noya, V de Waard, S. Gibbs, T. Broker, F. ten Kate, L. Chow and J. Ter Schegget, Transduction of the E6 and E7 genes of Epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures, J Invest Dermatol 117 (2001), 1397-1404.
133. B. Akgül, R. Garcia-Escudero, L. Ghali, H. Pfister, P. Fuchs, H. Navsaria and A. Storey, The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin, Cancer Res 65 (2005), 2216-2223.
134. M. Campo, M. Moar, W. Jarrett and H. Laird, A new papillomavirus associated with alimentary cancer in cattle, Nature 286 (1980), 180-182.
135. M. Campo, M. Moar, M. Sartirana, I. Kennedy and W. Jarrett, The presence of bovine papillomavirus type 4 DNA is not required for the progression to, or the maintenance of, the malignant state in cancers of the alimentary canal in cattle, EMBO J 4 (1985), 1819-1825.
136. M. Campo, B. O'Neil, R. Barron and W. Jarrett, Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle, Carcinogenesis 15 (1994), 1597-1601.
137. M. Jackson, M. Campo and J. Gaukroger, Cooperation between papillomavirus and chemical cofactors in oncogenesis, Crit Rev Oncog 4 (1993), 277-291.
138. H. Pfister, B. Fink and C. Thomas, Extrachromosomal bovine papillomavirus type 1 DNA in hamster fibromas and fibrosarcomas, Virology 115 (1981), 414-418.
139. N. Otten, C. von Tscharner, S. Lazary, D. Antczak and H. Gerber, DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing, Arch Virol 132 (1993), 121-131.
140. G. Chambers, V. Ellsmore, P. O'Brien, S. Reid, S. Love, M. Campo and L. Nasir, Association of bovine papillomavirus with the equine sarcoid, J Gen Virol 84 (2003), 1055-1062.
141. L. Bogaert, A. Martens, C. De Baere and F. Gasthuys, Detection of bovine papillomavirus DNA on the normal skin and in the habitual surroundings of horses with and without equine sarcoids, Res Vet Sci 79 (2005), 253-258.
142. H. Bernard, I. Calleja-Macias and S. Dunn, Genome variation of human papillomavirus types: phylogenetic and medical implications, Int J Cancer 118 (2006), 1071-1076.
143. F. Wettstein, M. Barbosa and M. Nasseri, Identification of the major cottontail rabbit papillomavirus late RNA cap site and mapping and quantitation of an E2 and minor E6 coding mRNA in papillomas and carcinomas, Virology 159 (1987), 321-328.
144. S. Watts, R. Ostrow, W. Phelps, J. Prince and A. Faras, Free cottontail rabbit papillomavirus DNA persists in warts and carcinomas of infected rabbits and in cells in culture transformed with virus or viral DNA, Virology 125 (1983), 127-138.
145. J. Brandsma, Z. Yang, S. Barthold and E. Johnson, Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required, Proc Natl Acad Sci USA 88 (1991), 4816-4820.
146. S. Jeckel, E. Huber, F. Stubenrauch and T. Iftner, A transactivator function of cottontail rabbit papillomavirus E2 is essential for tumor induction in rabbits, J Virol 76 (2002), 11209-11215.
147. E. Amtmann, M. Volm and K. Wayss, Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes, Nature 308 (1984), 291-292.
148. H. Müller and L. Gissmann, Mastomys natalensis papilloma virus (MnPV), the causative agent of epithelial proliferations: characterization of the virus particle, J Gen Virol 41 (1978), 315-323.
149. R. Rudolph, H. Müller, M. Reinacher and W. Thiel, Morphology of experimentally induced so-called keratoacanthomas and squamous cell carcinomas in 2 inbred-lines of Mastomys natalensis, J Comp Pathol 91 (1981), 123-134.
150. C. Tan, R. Tachezy, M. Van Ranst, S. Chan, H. Bernard and R. Burk, The Mastomys natalensis papillomavirus: Nucleotide sequence, genome organization, and phylogenetic relationship of a rodent papillomavirus involved in tumorigenesis of cutaneous epithelia, Virology 198 (1994), 534-541.
151. E. Amtmann, M. Volm and K. Wayss, The Mastomys natalensis papillomavirus, in: The Papoviridae, N. Salzmann and P. Howley, eds, Plenum Publishing Corporation, 1987, pp. 187-198.
152. J. Nafz, A. Köhler, M. Ohnesorge, I. Nindl, E. Stockfleth and F. Rösl, Presence and distribution of Mastomys natalensis papillomavirus in its natural host, submitted (2007).
153. J. Tinsley, C. Fisher and P. Searle, Abnormalities of epidermal differentiation associated with expression of the human papillomavirus type 1 early region in transgenic mice, J Gen Virol 73 (1992), 1251-1260.
154. I. Schaper, G. Marcuzzi, S. Weissenborn, H. Kasper, V. Dries, N. Smyth, P. Fuchs and H. Pfister, Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8, Cancer Res 65 (2005), 1394-1400.
155. W. Dong, U. Kloz, R. Accardi, S. Caldeira, W. Tong, Z. Wang, L. Jansen, M. Durst, B. Sylla, L. Gissmann and M. Tommasino, Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38, J Virol 79 (2005), 14899-14908.